Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M409101200 on January 4, 2005

J. Biol. Chem., Vol. 280, Issue 9, 7845-7853, March 4, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/9/7845    most recent
M409101200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, E. O.
Right arrow Articles by Chong, Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, E. O.
Right arrow Articles by Chong, Y. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Amyloid-{beta} Peptide Suppresses Transforming Growth Factor-{beta}1-induced Matrix Metalloproteinase-2 Production via Smad7 Expression in Human Monocytic THP-1 Cells*

Eun Ok Lee{ddagger}, Jihee Lee Kang§, and Young Hae Chong{ddagger}

From the Departments of {ddagger}Microbiology and §Physiology, College of Medicine, Division of Molecular Biology and Neuroscience, Ewha Medical Research Institute, Ewha Womans University, 911-1, Mok-6-dong, Yangcheonku, Seoul 158-710, Korea

Accumulation of the amyloid-{beta} (A{beta}) peptide in the brain is a crucial factor in the development of Alzheimer disease. Expression of transforming growth factor-{beta}1 (TGF-{beta}1), an immunosuppressive cytokine, has been associated in vivo with A{beta} accumulation in transgenic mice and recently with A{beta} clearance by activated microglia, suggesting its deleterious and beneficial effects in neuronal cells. In this study, we demonstrated that TGF-{beta}1 stimulated the production of matrix metalloproteinase-2 (MMP-2) in a time- and dose-dependent manner in a human monocytic THP-1 cell line. Notably, we found that A{beta}1–42 consistently inhibited the TGF-{beta}1-induced production of MMP-2, the endogenous gene containing Smad response elements, whereas the reverse peptide, A{beta}42–1, evidenced little effect. Additionally, A{beta}1–42 reduced TGF-{beta}1-induced increase in plasminogen activator inhibitor-1 (PAI-1). This inhibitory effect of A{beta}1–42 was also seen in human astroglial T98G cell line. Furthermore, A{beta}1–42 significantly induced the expression of Smad7, which appears in turn to mediate the A{beta} suppression of the TGF-{beta}1-induced MMP-2 production. Indeed, Smad7 overexpression mimicked the inhibitory effect of A{beta}1–42 on TGF-{beta}1-induced MMP-2 production. Importantly, A{beta}1–42 markedly suppressed the transactivation of the transfected reporter construct, p3TP-Lux, which contains TGF-{beta}1-inducible Smad response elements. This was concomitant with a decreased MMP-2 production in TGF-{beta}1-treated cells. Inhibition of cellular Smad7 levels via the small interference RNA method significantly ameliorated the A{beta}1–42-mediated suppression of TGF-{beta}1-inducible transcription reporter activity, thereby restoring MMP-2 induction, whereas Smad7 transfection down-regulated TGF-{beta}1-inducible transcription reporter activity. Collectively, these data suggest that A{beta}1–42 may play an important role in the negative regulation of TGF-{beta}1-induced MMP-2 production via Smad7 expression.


Received for publication, August 9, 2004 , and in revised form, December 1, 2004.

* This work was supported fully by the Ministry of Health and Welfare grant for Biomedical Brain Research (Neurodegenerative and Psychological Disease Research Grant 0405-NS01-0704–0001) and by Korea Research Foundation Grant KRF-2002-015-EP0071 (to Y. H. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Microbiology, College of Medicine, Ewha Woman's University, 911-1, Mok-6-dong, Yangcheonku, Seoul 158-710, Korea. Tel.: 822-02-2650-5739; Fax: 822-02-2653-8891; E-mail: younghae{at}ewha.ac.kr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. H. Chong, Y. J. Shin, E. O. Lee, R. Kayed, C. G. Glabe, and A. J. Tenner
ERK1/2 Activation Mediates Abeta Oligomer-induced Neurotoxicity via Caspase-3 Activation and Tau Cleavage in Rat Organotypic Hippocampal Slice Cultures
J. Biol. Chem., July 21, 2006; 281(29): 20315 - 20325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement